Artemis Wealth Advisors, LLC Abb Vie Inc. Transaction History

Artemis Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 17, 2023	SELL	$107.43 - $135.93 $35,989 - $45,536	-335 Closed	0 $0
Q3 2021 Sep 11, 2023	BUY	$106.4 - $120.78 $35,644 - $40,461	335 New	335 $36,000
Q3 2021 Feb 17, 2023	BUY	$106.4 - $120.78 $35,644 - $40,461	335 New	335 $36,000
Q2 2017 Feb 09, 2023	SELL	N/A	-69 Closed	0 $0
Q1 2017 Aug 29, 2023	BUY	N/A	69 New	69 $0
Q4 2016 Feb 09, 2023	BUY	N/A	69	69 $4,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Artemis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Artemis Wealth Advisors, LLC with notifications on news.